Intrexon (NASDAQ:XON) Shares Gap Up to $6.00

Intrexon Corp (NASDAQ:XON) gapped up before the market opened on Wednesday . The stock had previously closed at $6.29, but opened at $6.00. Intrexon shares last traded at $6.27, with a volume of 66234 shares traded.

Several brokerages recently issued reports on XON. Northland Securities downgraded Intrexon from an “outperform” rating to a “market perform” rating in a research report on Friday, March 1st. JMP Securities restated a “buy” rating and set a $43.00 price objective on shares of Intrexon in a report on Wednesday, March 6th. Finally, BidaskClub raised shares of Intrexon from a “sell” rating to a “hold” rating in a research report on Thursday, May 30th. One analyst has rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating to the stock. Intrexon presently has an average rating of “Hold” and a consensus target price of $28.60.

The company has a market cap of $868.13 million, a P/E ratio of -4.77 and a beta of 1.84. The company has a debt-to-equity ratio of 0.76, a quick ratio of 3.57 and a current ratio of 3.91.

Intrexon (NASDAQ:XON) last issued its earnings results on Thursday, May 9th. The biotechnology company reported ($0.28) earnings per share for the quarter, hitting the Zacks’ consensus estimate of ($0.28). The firm had revenue of $23.30 million during the quarter, compared to analysts’ expectations of $32.12 million. Intrexon had a negative net margin of 363.14% and a negative return on equity of 26.52%. The firm’s revenue for the quarter was down 41.2% compared to the same quarter last year. During the same period last year, the firm posted ($0.36) earnings per share. On average, research analysts forecast that Intrexon Corp will post -1.17 earnings per share for the current fiscal year.

In related news, major shareholder Randal J. Kirk sold 41,678 shares of the firm’s stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $0.67, for a total value of $27,924.26. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Randal J. Kirk sold 95,241 shares of the firm’s stock in a transaction that occurred on Wednesday, April 3rd. The stock was sold at an average price of $0.65, for a total transaction of $61,906.65. The disclosure for this sale can be found here. Insiders have purchased 3,402,182 shares of company stock valued at $15,739,033 over the last 90 days. 48.20% of the stock is currently owned by insiders.

TRADEMARK VIOLATION WARNING: “Intrexon (NASDAQ:XON) Shares Gap Up to $6.00” was first posted by Markets Daily and is owned by of Markets Daily. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of US and international copyright & trademark laws. The legal version of this piece can be accessed at https://www.themarketsdaily.com/2019/06/12/intrexon-nasdaqxon-shares-gap-up-to-6-00.html.

About Intrexon (NASDAQ:XON)

Intrexon Corporation operates in the synthetic biology field in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that consist of key genetic components. Its technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing; and ActoBiotics and AdenoVerse technology platforms.

Read More: NASDAQ

Receive News & Ratings for Intrexon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon and related companies with MarketBeat.com's FREE daily email newsletter.